Bradley Torphy, M.D.

Principal Investigator (Managing Director)
Chicago Headache Center and Research Institute, Chicago, Illinois, USA

Poster(s):

• (T 40) Ubrogepant Efficacy Based on Historical Cutaneous Allodynia and Triptan Response: Results from the PRODROME Trial

• (T 78) Patient Global Impression of Change Following Inpatient Treatment for Intractable Migraine

• (HE 22) Early Exposure, Lasting Impact: Educational Outcomes of the Chicago Headache Center & Research Institute 8-Week Intensive Summer Research Internship Program in Headache and Migraine Medicine